The very first study comprising a large number of subjects (n = 312) and investigating AD biomarkers, after extensive sample fractionation among 6000 detected MS signals identified 14 peptides derived from two proteins, one peptide from complement factor C3 (C3f) and the others were from VGF [64]. The gene discussed is LPCAT3; the disease is Alzheimer disease.